DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

HER2-positive Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Xichun Hu, PhD) · xchu2009@hotmail.com · 021-64175590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Breast Cancer · HER2-positive Breast Cancer · ER Positive Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Rochester, United States

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Breast Cancer · Breast Neoplasm · Breast Cancer Female

Abroad (travel likely)RecruitingPHASE2

Houston, United States · Houston, United States

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

HER2-positive Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Bengbu, China · Fuyang, China

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Zhengzhou, China